ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality, substance misuse, transport accidents, and criminality, according to a study published online Aug. 13 in The BMJ.
Le Zhang, M.P.H., from the Karolinska Institutet in Stockholm, and colleagues examined the effects of drug treatment for ADHD on suicidal behaviors, substance misuse, accidental injuries, transport accidents, and criminality in an emulation of target trials involving people aged 6 to 64 years with a new diagnosis of ADHD. First and recurrent events of five outcomes were examined over two years after ADHD diagnosis.
Of 148,581 individuals with ADHD, 56.7 percent started drug treatment for ADHD; methylphenidate was prescribed most commonly at initiation (88.4 percent). The researchers found that drug treatment for ADHD was associated with significantly reduced rates of the first occurrence of suicidal behaviors, substance misuse, transport accidents, and criminality (adjusted incidence rate ratios, 0.83, 0.85, 0.88, and 0.87, respectively), while the reduction in accidental injuries was not statistically significant. Individuals with previous events had more pronounced reduced rates, with incidence rate ratios varying from 0.79 to 0.97 for suicidal behaviors and accidental injuries, respectively. Drug treatment was significantly associated with reduced rates of all five outcomes for recurrent events (0.85, 0.75, 0.96, 0.84, and 0.75 for suicidal behaviors, substance misuse, accidental injuries, transport accidents, and criminality, respectively).
"These results provide evidence on the effects of ADHD drug treatment on important health related and social outcomes that should inform clinical practice and the debate on the drug treatment of ADHD," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D)...
Six in 10 Children With Asthma Meet Guideline Diagnostic Criteria
THURSDAY, Aug. 14, 2025 -- Roughly two-thirds of children with pediatrician-diagnosed asthma have a confirmed diagnosis in accordance with international guideline criteria...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.